Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Total Non-Current Liabilities (2019 - 2025)

Updated

Aligos Therapeutics (ALGS) reported Total Non-Current Liabilities of $47,000 for Q4 2025, up 2.2% from $46,000 a year earlier and up 2.2% from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends

Dating back to Q4 2019, Aligos Therapeutics' Total Non-Current Liabilities record includes 21 quarters.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of -34.1% (FY2020 to FY2025).
  • By year, Total Non-Current Liabilities came in at $46,000 in FY2024 (unchanged), $46,000 in FY2023, -$2.01 billion in FY2022 and $133,000 in FY2021 (-64.9%).
  • The Q4 2025 figure ranks as the highest quarterly Total Non-Current Liabilities since Q3 2022.
  • Year over year, Total Non-Current Liabilities gained in 1 of the last six quarters, with growth averaging 0.4%.
  • The high point for year-over-year Total Non-Current Liabilities in five years was Q1 2022 (growth of 47.1%); the low point was Q3 2023 (a decline of 99.9%).
  • Per Business Quant data, the three quarters before Q4 2025 came in at $46,000 (Q3 2025), $46,000 (Q2 2025) and $46,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 102.65 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 117.60 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 36.05 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 96.04 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 47,000.00
Sep 30, 2025 46,000.00
Jun 30, 2025 46,000.00
Mar 31, 2025 46,000.00
Dec 31, 2024 46,000.00
Sep 30, 2024 46,000.00
Jun 30, 2024 46,000.00
Mar 31, 2024 46,000.00
Dec 31, 2023 46,000.00
Sep 30, 2023 46,000.00
Dec 31, 2022 -2.01 Bn
Sep 30, 2022 41.92 Mn
Jun 30, 2022 45.41 Mn
Mar 31, 2022 57.45 Mn
Dec 31, 2021 133,000.00
Sep 30, 2021 45.79 Mn
Jun 30, 2021 42.73 Mn
Mar 31, 2021 39.05 Mn
Dec 31, 2020 379,000.00
Sep 30, 2020 227.94 Mn
API Access

Aligos Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ALGS&period=max&api_key=YOUR_API_KEY